4737 — Bionime Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapMomentum Trap

Annual cashflow statement for Bionime, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	74.6	86.5	-31.9	-186	-249
Depreciation
Amortisation
Non-Cash Items	10.6	71.3	12.2	101	130
Unusual Items
Other Non-Cash Items
Changes in Working Capital	29.9	-169	59.7	-78.5	432
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	270	142	203	19.5	495
Capital Expenditures	-285	-313	-441	-333	-288
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-3.5	0.665	6.14	-4.08	2.32
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities	-288	-312	-435	-337	-286
Financing Cash Flow Items	0.557	-0.071	-1.08	-0.056	1.78
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-69.3	114	420	217	-109
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-90.2	-38.6	177	-70.6	102